For example, ketogenic diets should be used with caution or avoided in individuals with type 1 diabetes, advanced type 2 diabetes treated with insulin or SGLT2 inhibitors (due to risk of ketoacidosis), disorders of fatty acid oxidation, or hepatic and renal insufficiency [63]. This evidence concerns the gene SLC5A2 and type 1 diabetes mellitus.